Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-07-002860
Filing Date
2007-02-05
Accepted
2007-02-05 20:33:50
Documents
2
Period of Report
2007-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 5574
2 POWER OF ATTORNEY ex24poarwilson.txt EX-24 3678
  Complete submission text file 0001179110-07-002860.txt   10892
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JOHNSON & JOHNSON ONE JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address 732 524 2455
WILSON ROBERT N (Reporting) CIK: 0001189022 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 07582327